Medical Cannabis for Inflammatory Bowel Disease: Study
Introduction and Background
The systematic review and meta-analysis by Smith and Evans published in Clinical Gastroenterology and Hepatology addresses the growing interest in medical cannabis as a treatment for inflammatory bowel disease (IBD). The introduction effectively outlines the challenges associated with current IBD treatments, such as corticosteroids and immunosuppressants, which often carry significant side effects. This section also provides a solid rationale for exploring alternative therapies like medical cannabis, which may offer anti-inflammatory and analgesic benefits. By highlighting the need for …